Nanosonics (OTCMKTS:NNCSF) Shares Down 17.5% – Time to Sell?
by Amy Steele · The Cerbat GemNanosonics Limited (OTCMKTS:NNCSF – Get Free Report)’s stock price was down 17.5% on Friday . The stock traded as low as $2.16 and last traded at $2.31. Approximately 2,600 shares traded hands during trading, an increase of 117% from the average daily volume of 1,200 shares. The stock had previously closed at $2.80.
Analyst Upgrades and Downgrades
Separately, Royal Bank Of Canada raised shares of Nanosonics from an “underperform” rating to a “sector perform” rating in a research note on Monday, January 19th. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, Nanosonics has an average rating of “Hold”.
View Our Latest Stock Report on Nanosonics
Nanosonics Stock Down 17.5%
The stock has a 50 day simple moving average of $2.43 and a 200-day simple moving average of $2.64.
Nanosonics Company Profile
Nanosonics Limited is an Australia‐based medical technology company specializing in infection prevention solutions for the healthcare sector. Founded in 2001 and headquartered in Sydney, the company is best known for developing and commercializing its proprietary Trophon platform, which provides automated high‐level disinfection of ultrasound probes using sonically activated hydrogen peroxide vapor. Nanosonics holds numerous patents and regulatory approvals across multiple jurisdictions, positioning it as a leader in point‐of‐care decontamination.
The company’s flagship product, Trophon EPR, is designed to address the critical need for rapid, reliable disinfection of endocavity and surface ultrasound transducers.